Health & Fitness
Health and Fitness
Health and Fitness
Tue, June 14, 2011
Mon, June 13, 2011
Fri, June 10, 2011 Gilead Sciences Receives Subpoena from U.S. Department of Justice
FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has received a subpoena from the United States Attorneya™s Office for the Northern District of California requesting documents related to the manufacture, and related quality and distribution practices, of Atripla®, Emtriva®, Hepsera®, Letairis®, Truvada®, Viread® and our investigational fixed-dose combination of Truvada and EdurantTM. Gilead is cooperating in this civil and criminal investigation.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companya™s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.
Emtriva, Hepsera, Letairis, Truvada and Viread are registered trademarks of Gilead Sciences, Inc.
Atripla is a registered trademark of Bristol-Myers Squibb & Gilead Sciences, LLC.
Edurant is a trademark of Tibotec Pharmaceuticals.
For more information on Gilead Sciences, please visit the company's website at [ www.gilead.com ] or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
